Document is current
Any future updates will be listed below
-
Authors
Kawahara, Naoki http://orcid.org/0000-0003-1154-2481
Kawaguchi, Ryuji
Yamamoto, Konosuke
Nishikawa, Kyohei
Matsuoka, Motoki
Maehana, Tomoka
Fukui, Yosuke
Yamanaka, Shoichiro
Sugimoto, Sumire
Iwai, Kana
Yamada, Yuki
Kurakami, Hiroyuki
Hirata, Takumi
Takashima, Ryuzo
Suzuki, Shota
Asada, Kiyoshi
Kasahara, Masato
Kimura, Fuminori
- License Information
-
More Information
Article History
Received: 23 September 2023
Accepted: 9 January 2024
First Online: 19 January 2024
Declarations
:
: This study protocol was approved by the Certified Review Board in Nara Medical University (CRB5200002). The principal investigator will fix the data and publish the result after the registration to the jRCT. The CRFs and collation sheets will be stored in a vault at the data center. After the completion of the study, they will be stored for 5 years and disposed of with the information processed in such a way that specific individuals cannot be identified.The current protocol adheres to the Standard Protocol Items for Randomized Trials guidelines [CitationRef removed] and is registered with jRCT. This study has been approved by the Nara Medical University Clinical Research Grant Program. Informed and written consent is obtained from patients at the point of recruitment.
: Not applicable.
: The authors declare that they have competing interests with ASKA Pharmaceutical Co., Ltd. because this research was funded and supported with the provision of the relugolix.
